カテゴリ： MarketLine, オーストラリア, 企業調査

Sigma Pharmaceuticals Limited：戦略・SWOT・企業財務分析

◆英語タイトル：Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015434
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：小売
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Sigma Pharmaceuticals Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sigma Pharmaceuticals Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sigma Pharmaceuticals (Sigma or ‘the company’) is a wholesaler and distributor of pharmaceutical products. The company operates a pharmacy-led network in Australia, with over 1,200 branded and independent pharmacies. It is headquartered in Rowville, Victoria.

Scope

- Detailed information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sigma Pharmaceuticals Limited including a breakdown and examination of key business segments
- Intelligence on Sigma Pharmaceuticals Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sigma Pharmaceuticals Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sigma Pharmaceuticals Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sigma Pharmaceuticals Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sigma Pharmaceuticals Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Sigma Pharmaceuticals Limited: Company Overview
Sigma Pharmaceuticals Limited: Overview and Key Facts
Sigma Pharmaceuticals Limited: Overview
Sigma Pharmaceuticals Limited: Key Facts
Sigma Pharmaceuticals Limited: Key Employees
Sigma Pharmaceuticals Limited: Key Employee Biographies
Sigma Pharmaceuticals Limited: Major Products and Services
Sigma Pharmaceuticals Limited: Company History
Sigma Pharmaceuticals Limited: Management Statement
Sigma Pharmaceuticals Limited: Locations and Subsidiaries
Sigma Pharmaceuticals Limited: Key Competitors
Sigma Pharmaceuticals Limited: Company Analysis
Sigma Pharmaceuticals Limited: Business Description
Sigma Pharmaceuticals Limited: SWOT Analysis
Sigma Pharmaceuticals Limited: SWOT Overview
Sigma Pharmaceuticals Limited: Strengths
Sigma Pharmaceuticals Limited: Weaknesses
Sigma Pharmaceuticals Limited: Opportunities
Sigma Pharmaceuticals Limited: Threats
Sigma Pharmaceuticals Limited: Corporate Financial Deals Activity
Sigma Pharmaceuticals Limited: Financial Deals Overview
Sigma Pharmaceuticals Limited: Targets and Partners
Sigma Pharmaceuticals Limited: Top Deals 2013 – 2017YTD*
Sigma Pharmaceuticals Limited: Mergers and Acquisitions
Sigma Pharmaceuticals Limited: Recent Developments
Sigma Pharmaceuticals Limited: News and Events Summary
Sigma Pharmaceuticals Limited: Contracts
Sigma Pharmaceuticals Limited: Corporate Governance
Sigma Pharmaceuticals Limited: Financial Deals
Sigma Pharmaceuticals Limited: Financial Performance
Sigma Pharmaceuticals Limited: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Sigma Pharmaceuticals Limited: Key Facts
Table 2: Sigma Pharmaceuticals Limited: Key Employees
Table 3: Sigma Pharmaceuticals Limited: Locations and Subsidiaries
Table 4: Sigma Pharmaceuticals Limited: Key Competitors
Table 5: Sigma Pharmaceuticals Limited: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Sigma Pharmaceuticals Limited: M&A Average Deal Size - Value (US$m)
Table 7: Sigma Pharmaceuticals Limited: Targets and Partners
Table 8: Sigma Pharmaceuticals Limited: Top Deals 2013 - 2017YTD*
Table 9: Sigma Pharmaceuticals Limited: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Sigma Pharmaceuticals Limited: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Sigma Pharmaceuticals Limited: News and Events Summary
Table 12: Sigma Pharmaceuticals Limited: Contracts
Table 13: Sigma Pharmaceuticals Limited: Corporate Governance
Table 14: Sigma Pharmaceuticals Limited: Financial Deals
Table 15: Sigma Pharmaceuticals Limited: Financial Performance
Table 16: Sigma Pharmaceuticals Limited: Strategy and Operations

★海外企業調査レポート[Sigma Pharmaceuticals Limited：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Impel NeuroPharma Inc：医療機器：M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …
  • Immofinanz AG：企業のM&A・事業提携・投資動向
    Immofinanz AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Immofinanz AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Ikkuma Resources Corp (IKM)：石油・ガス：M&Aディール及び事業提携情報
    Summary Ikkuma Resources Corp (Ikkuma), formerly PanTerra Resource Corp is an oil and gas exploration and development company that operates conventional and unconventional projects. The company conducts drilling operations in Foothills region of Alberta and British Columbia, Canada. It also gathers …
  • Defence Research and Development Organisation：企業の戦略・SWOT・財務情報
    Defence Research and Development Organisation - Strategy, SWOT and Corporate Finance Report Summary Defence Research and Development Organisation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Beacon Discovery Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Beacon Discovery Inc (Beacon Discovery) is an independent drug discovery incubator that focuses on identifying and advancing molecules targeting G-Protein Coupled Receptors (GPCRs) from concept to clinic. The company works in collaboration with pharma and biotech companies to discover and de …
  • Southwestern Electric Power Co：企業の戦略的SWOT分析
    Southwestern Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Oaks Hotels & Resorts Limited：企業の戦略・SWOT・財務分析
    Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report Summary Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ceres Power Holdings Plc (CWR)：電力：M&Aディール及び事業提携情報
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Repsol SA (REP)：企業の財務・戦略的SWOT分析
    Repsol SA (REP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Rostelecom：企業の戦略・SWOT・財務情報
    Rostelecom - Strategy, SWOT and Corporate Finance Report Summary Rostelecom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cancer Genetics Inc (CGIX)：企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • EnBW Energie Baden-Wurttemberg AG (EBK)：電力：M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Iwatani Corporation (8088)：企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pakistan Water and Power Development Authority：発電所・企業SWOT分析
    Pakistan Water and Power Development Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Sopheon Plc：企業の戦略・SWOT・財務情報
    Sopheon Plc - Strategy, SWOT and Corporate Finance Report Summary Sopheon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Spark Infrastructure Group (SKI)：企業の財務・戦略的SWOT分析
    Spark Infrastructure Group (SKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Terex Corporation：企業の戦略・SWOT・財務情報
    Terex Corporation - Strategy, SWOT and Corporate Finance Report Summary Terex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • QNB Finansbank (QNBFB)：企業の財務・戦略的SWOT分析
    QNB Finansbank (QNBFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Natrix Separations Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hyd …
  • Chembio Diagnostic, Inc. (CEMI)-医療機器分野：企業M&A・提携分析
    Summary Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes P …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆